Symptoms of Schizophrenia: Methods, Meanings, and Mechanisms

Archives of General Psychiatry

Volumn 52, Issue 5, 1995, Pages 341-351

  Andreasen, Nancy C ^a   Arndt, Stephan ^a   Alliger, Randall ^a   Miller, Del ^a   Flaum, Michael ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFFECT; ANHEDONIA; ARTICLE; DELUSION; DISEASE CLASSIFICATION; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROGNOSIS; RATING SCALE; SCHIZOPHRENIA; SYMPTOMATOLOGY;

AGE OF ONSET; BIPOLAR DISORDER; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMAN; LIKELIHOOD FUNCTIONS; MALE; MODELS, NEUROLOGICAL; MODELS, PSYCHOLOGICAL; MODELS, STATISTICAL; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SCHIZOTYPAL PERSONALITY DISORDER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TERMINOLOGY;

EID: 0028997391     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1995.03950170015003     Document Type: Article

References (117)

1. Andreasen NC. The diagnosis of schizophrenia. Schizophr Bull. 1987;13: 9–22.
2. Andreasen NC, Flaum M. Schizophrenia: the characteristic symptoms. Schizophr Bull. 1991;17: 27–49.
3. Andreasen NC, Carpenter WT. Diagnosis and classification of schizophrenia. Schizophr Bull. 1993;19: 199–214.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
5. World Psychiatric Association. International Classification and Diagnosis-10. Geneva, Switzerland: World Health Organization; 1993.
6. Bleuler E; Zinkin J, trans. Dementia Praecox of the Group of Schizophrenias (1911). New York, NY: International Universities Press; 1950.
7. Kraepelin E, Barclay RM, Robertson GM. Dementia Praecox and Paraphrenia. Edinburgh, Scotland: E & S Livingstone; 1919.
8. Mellor CS. First-rank symptoms of schizophrenia. Br J Psychiatry. 1970;117: 15–23.
9. Schneider K; Hamilton MW, trans. Clinical Psychopathology. New York, NY: Grune & Stratton Inc; 1959.
10. Schneider K. Primary and secondary symptoms in schizophrenia. In: Hirsch SR, Sheperds M, eds. Themes and Variations in European Psychiatry. Bristol, England: John Wright & Sons Ltd; 1974: 40–46.
11. Taylor MA. Schneiderian first-rank symptoms and clinical prognostic features in schizophrenia. Arch Gen Psychiatry. 1972;26: 64–67.
12. Abrams R, Taylor M. First-rank symptoms, severity of illness, and treatment response in schizophrenia. Compr Psychiatry. 1973;14: 353–355.
13. Carpenter WT Jr, Strauss JS, Muleh S. Are there pathognomonic symptoms in schizophrenia? an empirical investigation of Schneider's first-rank symptoms. Arch Gen Psychiatry. 1973;28: 847–852.
14. Carpenter WT Jr, Heinrichs DW, Alphs LD. Treatment of negative symptoms. Schizophr Bull. 1985;11: 440–452.
15. Andreasen NC, Akiskal HS. The specificity of Bleulerian and Schneiderian symptoms: a critical reevaluation. Psychiatr Clin North Am. 1983;6: 41–54.
16. Kendell RE, Cooper JE, Gourlay AG. Diagnostic criteria of American and British psychiatrists. Arch Gen Psychiatry. 1971;25: 123–130.
17. Wing JK, Cooper JE, Sartorius N. The Measurement and Classification of Psychiatric Symptoms. Cambridge, England: Cambridge University Press; 1974.
18. Wing J, Nixon J. Discriminating symptoms in schizophrenia: a report from the international pilot study of schizophrenia. Arch Gen Psychiatry. 1975;32: 853–859.
19. Pope HG Jr, Lipinski JF Jr. Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of ‘schizophrenic’ symptoms in the light of current research. Arch Gen Psychiatry. 1978;35: 811–828.
20. Andreasen NC. Thought, language, and communication disorders, I: clinical assessment, definition of terms, and evaluation of their reliability. Arch Gen Psychiatry. 1979;36: 1315–1321.
21. Andreasen NC. Thought, language, and communication disorders, II: diagnostic significance. Arch Gen Psychiatry. 1979;36: 1325–1330.
22. Lewine R, Renders R, Kirchhofer M, Monsour A, Watt N. The empirical heterogeneity of first-rank symptoms in schizophrenia. Br J Psychiatry. 1982;140: 498–502.
23. Harrow M, Grinker RR Sr, Silverstein ML, Holzman P. Is modern-day schizophrenic outcome still negative. Am J Psychiatry. 1978;135: 1156–1162.
24. Andreasen NC. Affective flattening and the criteria for schizophrenia. Am J Psychiatry. 1979;136: 944–947.
25. Reynolds JR. Essays and Addresses. London, England: Macmillan Publishing Co; 1896.
26. Jackson JH. Selected Writings of J.H. Jackson. London, England: Hodder & Stoughton; 1931.
27. Berrios GE. Positive and negative signals: a conceptual history. In: Marnero SA, Andreasen NC, Tsuang MT, eds. Negative Versus Positive Schizophrenia. Berlin, Germany: Springer-Verlag Berlin; 1991: 8–27.
28. Strauss JS, Carpenter WT, Bartko JJ. The diagnosis and understanding of schizophrenia, III: speculations on the processes that underlie schizophrenia symptoms and signs. Schizophr Bull. 1974;1: 61–69.
29. Crow TJ. Molecular pathology of schizophrenia: more than one disease process? BMJ. 1980;280: 66–68.
30. Andreasen NC. Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry. 1982;39: 784–788.
31. Andreasen NC, Olsen S. Negative vs positive schizophrenia: definition and validation. Arch Gen Psychiatry. 1982;39: 789–794.
32. Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City: The University of Iowa; 1983.
33. Andreasen NC. The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: The University of Iowa; 1984.
34. Andreasen NC. Positive vs negative schizophrenia: a critical evaluation. Schizophr Bull. 1985;11: 380–389.
35. Andreasen NC. Negative syndrome in schizophrenia: strategies for long-term management. Adv Biochem Psychopharmacol. 1985;40: 1–7.
36. Andreasen NC, Grove WM. Evaluation of positive and negative symptoms in schizophrenia. Psychiatr Psychobiol. 1986;2: 108–121.
37. Andreasen NC. The concept of negative symptoms: definition, specificity, and significance. Psychiatr Psychobiol. 1987;4: 240–251.
38. Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry. 1989;155(suppl 7): 49–52.
39. Andreasen NC. Methods for assessing positive and negative symptoms. In: Andreasen NC, ed. Schizophrenia: Positive and Negative Symptoms and Syndromes. Modern Problems in Pharmacopsychiatry. Basel, Switzerland: Karger; 1990: 73–88.
40. Andreasen NC. Positive and negative symptoms: historical and conceptual aspects. In: Andreasen NC, ed. Schizophrenia: Positive and Negative Symptoms and Syndromes. Modern Problems of Pharmacopsychiatry. Basel, Switzerland: Karger; 1990: 1–42.
41. Andreasen NC, Flaum M, Swayze VW, Tyrrell G, Arndt S. Positive and negative symptoms in schizophrenia: a critical reappraisal. Arch Gen Psychiatry. 1990;47: 615–621.
42. Andreasen NC, Flaum M, Arndt S, Alliger R, Swayze VW. Positive and negative symptoms: assessment and validity. In: Marneros A, Andreasen NC, Tsuang MT, eds. Negative Versus Positive Schizophrenia. Berlin, Germany: Springer-Verlag Berlin; 1991: 28–51.
43. Carpenter WT Jr, Heinrichs DW, Wagman AMI. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry. 1989;145: 578–583.
44. Carpenter WT, Strauss JS, Bartko JJ. On the heterogeneity of schizophrenia. In: Alpert M, ed. Controversies in Schizophrenia. New York, NY: Guilford Press; 1985: 25–37.
45. Lewine RR, Fogg L, Meltzer HY. Assessment of negative and positive symptoms in schizophrenia. Schizophr Bull. 1983;9: 368–376.
46. Liddle PF. Schizophrenic syndromes, cognitive performance, and neurological dysfunction. Psychol Med. 1987;7: 49–57.
47. Gibbons RD, Lewine RR, Davis JM, Schooler NR, Cole JD. An empirical test of a Kraepelinian vs a Bleulerian view of negative symptoms. Schizophr Bull. 1985;11: 390–396.
48. Marneros A, Deister A, Rohde A. Long-term monomorphism of negative and positive schizophrenic episode. In: Marneros A, Andreasen NC, Tsuang MT, eds. Negative Versus Positive Schizophrenia. Berlin, Germany: Springer-Verlag Berlin; 1991: 183–196.
49. Sommers AS. ‘Negative symptoms’: conceptual and methodological problems. Schizophr Bull. 1985;11: 364–373.
50. Pogue-Geile MF, Harrow M. Negative symptoms in schizophrenia: their longitudinal course and prognostic importance. Schizophr Bull. 1985;11: 427–439.
51. Goldberg SC. Negative and deficit symptoms in schizophrenia do respond to neuroleptics. Schizophr Bull. 1985;11: 453–456.
52. Andreasen NC, ed. In: Schizophrenia: Positive and Negative Symptoms and Syndromes. Modern Problems of Pharmacopsychiatry. Basel, Switzerland: Karger; 1990.
53. Fish FJ. Schizophrenia. Bristol, England: John Wright & Sons Ltd; 1962.
54. Carpenter WT Jr, Strauss JS, Bartko JJ. Beyond diagnosis: the phenomenology of schizophrenia. Am J Psychiatry. 1981;138: 948–953.
55. Andreasen NC. Brain imaging: applications in psychiatry. Science. 1988;239: 1381–1388.
56. Andreasen NC. Can Schizophrenia Be Localized in the Brain? Washington, DC: American Psychiatric Press Inc; 1986.
57. Andreasen NC, Swayze VW II, Flaum M, O'Leary DS, Alliger R. The neural mechanisms of mental phenomena. In: Andreasen NC, ed. Schizophrenia: From Mind to Molecule. Washington, DC: American Psychiatric Press Inc; 1994: 49–91.
58. Andreasen NC, Flaum M, Arndt S. The Comprehensive Assessment of Symptoms and History (CASH): an instrument for assessing psychopathology and diagnosis. Arch Gen Psychiatry. 1992;49: 615–623.
59. Johnstone EC, Owens DGC, Frith CD, Crow TJ. The relative stability of positive and negative features in chronic schizophrenia. Br J Psychiatry. 1987;150: 65–71.
60. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT. The Schedule for the Deficit Syndrome: an instrument for research in schizophrenia. Psychiatr Res. 1989;30: 119–124.
61. Lindenmayer JP, Kay SR, Friedman C. Negative and positive schizophrenic syndromes after the acute phase: a prospective follow-up. Compr Psychiatry. 1986;27: 276–286.
62. Pogue-Geile MF, Harrow M. Negative and postive symptoms in schizophrenia and depression: a follow-up. Schizophr Bull. 1984;10: 371–387.
63. Greden JF, Tandon R, eds. Negative Schizophrenic Symptoms: Pathophysiology and Clinical Implications. Washington, DC: American Psychiatric Press; 1990.
64. Meltzer HY. Dopamine and negative symptoms in schizophrenia: critique of the type I-type II hypothesis. In: Alpert M, ed. Controversies in Schizophrenia: Changes and Constancies. New York, NY: Guilford Press; 1985: 110–136.
65. Meltzer HY, Sommers AA, Luchins DJ. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia. J Clin Psychopharmacol. 1986;6: 329–338.
66. Trimble MR. Positive and negative symptoms in psychiatry. Br J Psychiatry. 1986;148: 587–589.
67. Angrist B, Rotrosen J, Gershon S. Differential effects of amphetamine and neuroleptics on negative vs positive symptoms in schizophrenia. Psychopharmacology (Berlin). 1980;72: 17–19.
68. Angrist B, Peselow E, Rubinstein M, Corwin J, Rotrosen J. Partial improvement in negative schizophrenic symptoms after amphetamine. Psychopharmacology (Berlin). 1982;78: 128–130.
69. Buchanan RW, Kirkpatrick B, Tamminga CA. Differential patterns of glucose metabolism in deficit and non-deficit schizophrenia. Biol Psychiatry. 1989;27(suppl): 99A–100A.
70. Buchanan RW, Kirkpatrick B, Heinrichs DW, Carpenter WT. Clinical correlates of the deficit syndrome of schizophrenia. Am J Psychiatry. 1990;147: 290–294.
71. Kirkpatrick B, Buchanan RW. Anhedonia and the deficit syndrome of schizophrenia. Psychiatry Res. 1990;31: 25–30.
72. Wagman AMI, Heinrichs DW, Carpenter WT. The deficit and non-deficit forms of schizophrenia: neuropsychological evaluation. Psychiatry Res. 1987;22: 319–330.
73. Gross G. The ‘basic’ symptoms of schizophrenia. Br J Psychiatry. 1989;155(suppl 7): 21–25.
74. Walker E, Lewine RJ. The positive/negative symptom distinction in schizophrenia: validity and etiological relevance. Schizophr Res. 1988;1: 315–328.
75. Dworkin RH, Lenzenweger MF. Symptoms and the genetics of schizophrenia: implications for diagnosis. Am J Psychiatry. 1984;41: 1541–1546.
76. Dworkin RH, Lenzenweger MF, Moldin SO, Skillings GF, Levick SE. A multidimensional approach to the genetics of schizophrenia. Am J Psychiatry. 1988;145: 1077–1083.
77. Johnstone EC, Owens DGC, Firth CD, Crow TJ. The relative stability of positive and negative features in chronic schizophrenia. Br J Psychiatry. 1986;150: 60–64.
78. Kemali D, Maj M, Galderisi S, Salvati A, Starace F, Valente A, Pirozzi R. Clinical, biological, and neuropsychological features associated with lateral ventricular enlargement in DSM-III schizophrenic disorder. Psychiatry Res. 1986;21: 137–149.
79. Mackay AVP. Positive and negative schizophrenic symptoms and the role of dopamine. Br J Psychiatry. 1980;137: 379–383.
80. Tandon R, Greden JF. Cholinergic hyperactivity and negative schizophrenic symptoms: a model of cholinergic/dopaminergic interactions in schizophrenia. Arch Gen Psychiatry. 1989;46: 745–753.
81. Tandon R, Goldman RS, Goodson JA, Greden JF. Mutability and relationship between positive and negative symptoms during neuroleptic treatment in schizophrenia. Biol Psychiatry. 1990;27: 1323–1326.
82. van Kammen DP, Hommer DW, Malas KL. Effect of pimozide on positive and negative symptoms in schizophrenic patients: are negative symptoms dependent? Neuropsychobiology. 1987;18: 113–117.
83. van Kammen DP, Peters JL, Rosen J, van Kammen WB, Neylan T, Shaw D, Linnoila M. Norepinephrine in acute exacerbations of chronic schizophrenia: negative symptoms revisited. Arch Gen Psychiatry. 1990;47: 161–168.
84. Wing JK. The concept of negative symptoms. Br J Psychiatry. 1989;155(suppl 7): 10–14.
85. Liddle PF, Friston KJ, Frith CD, Frackowiak RSJ. Cerebral blood flow and mental processes in schizophrenia. JR Soc Med. 1992;85: 224–226.
86. Liddle PF. The symptoms of chronic schizophrenia: a re-examination of the positive-negative dichotomy. Br J Psychiatry. 1987;151: 145–151.
87. Liddle PF, Barnes TRE. Syndromes of chronic schizophrenia. Br J Psychiatry. 1990;157: 558–561.
88. Liddle PF, Morris D. Schizophrenic syndromes and frontal lobe performance. Br J Psychiatry. 1991;158: 340–345.
89. Frith CD, Done DJ. Towards a neuropsychology of schizophrenia. Br J Psychiatry. 1988;153: 437–443.
90. Frith CR, Done DJ. Experiences of alien control in schizophrenia reflect a disorder in the central monitoring of action. Psychol Med. 1989;19: 359–363.
91. McGlashan TH, Fenton WS. The positive-negative distinction in schizophrenia: review of natural history validators. Arch Gen Psychiatry. 1992;49: 63–72.
92. Fenton WS, McGlashan TH. Natural history of schizophrenia subtypes: II, positive and negative symptoms and long-term course. Arch Gen Psychiatry. 1991;48: 978–986.
93. Bogerts B, Lieberman JA, Ashtari M, Bilder RM, Degreef G, Lerner G, Johns C, Masiar S. Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biol Psychiatry. 1993;33: 236–246.
94. Ohta T, Okazaki Y, Anzai N. Reliability of the Japanese version of the Scale for the Assessment of Negative Symptoms (SANS). Jpn J Clin Psychiatr. 1984;13: 1123–1131.
95. Humbert M, Salvador L, Segui J, Obiols J, Obiols J. Estudio interfiabilidad version espanola evaluacion de sintomas positivos y negativos. Rev Departmento Psiquiatria Facultad de Medicine, University of Barcelona. 1986;13: 28–36.
96. Moscarelli M, Maffei C, Cesana BM. An international perspective on assessment of negative and positive symptoms in schizophrenia. Am J Psychiatry. 1987;144: 1595–1598.
97. Arndt S, Alliger RJ, Andreasen NC. The distinction of positive and negative symptoms: the failure of a two-dimensional model. Br J Psychiatry. 1991;158: 317–322.
98. Miller DD, Arndt S, Andreasen NC. Alogia, attentional impairment, and inappropriate affect: their status in the dimensions of schizophrenia. Compr Psychiatry. 1993;34: 221–226.
99. Bilder RM, Mukherjee S, Rieder RO, Pandurangi AK. Symptomatic and neuropsychological components of defect states. Schizophr Bull. 1985;11: 409–491.
100. Kulhara P, Kota SK, Joseph S. Positive and negative subtypes of schizophrenia: a study from India. Acta Psychiatr Scand. 1986;74: 353–359.
101. Lenzenweger MF, Dworkin RH, Wethington E. Models of positive and negative symptoms in schizophrenia: an empirical evaluation of latent structures. J Abnorm Psychol. 1989;98: 62–70.
102. Schuldberg D, Quinlan DM, Morgenstern H, Glazer W. Positive and negative symptoms in chronic psychiatric outpatients: reliability, stability, and factor structure. Psychological Assessment: J Consult Clin Psychol. 1990;2: 262–268.
103. Gur RE, Mozley D, Resnick SM, Levick S, Erwin R, Saykin AJ, Gur RC. Relations among clinical scales in schizophrenia. Am J Psychiatry. 1991;148: 472–478.
104. Minas IH, Stuart GW, Klimidis S, Jackson HJ, Singh BS, Copolov DL. Positive and negative symptoms in the psychoses: multidimensional scaling of SAPS and SANS items. Schizophr Res. 1992;8: 143–156.
105. Brown KW, White T. Syndromes of chronic schizophrenia and some clinical correlates. Br J Psychiatry. 1992;161: 317–322.
106. Peralta V, de Leon J, Cuesta MJ. Are there more than two syndromes in schizophrenia? a critique of the positive-negative dichotomy. Br J Psychiatry. 1992;161: 335–343.
107. Gorsuch RL. Factor Analysis. Philadelphia, Pa: WB Saunders Co; 1974.
108. Andreasen NC, Grove WM. Thought, language, and communication in schizophrenia: diagnosis and prognosis. Schizophr Bull. 1986;12: 348–359.
109. Arndt S, Andreasen NC, Flaum M, Miller D, Nopoulos P. A longitudinal study of symptom dimensions in schizophrenia: prediction and patterns of change. Arch Gen Psychiatry. 1995;52: 352–360.
110. Weinberger DR, Berman KF, Zec RF. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia, I: regional cerebral blood flow (rCBF) evidence. Arch Gen Psychiatry. 1986;43: 114–124.
111. Buchsbaum MS. The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophr Bull. 1990;16: 379–384.
112. Andreasen NC, Flaum M, Arndt S, Alliger R, Miller D, O'Leary D. Positive and negative symptoms and syndromes: assessment and biological correlates. In: Ferrero F, Haynal AE, Sartorius N, eds. Schizophrenia and Affective Psychoses: Nosology in Contemporary Psychiatry. New York, NY: John Libbey; 1992.
113. Buchsbaum MS, Ingvar DH, Kessler R, Waters RN, Capelletti J, Kammen DP, King C, Johnson J, Manning RG, Flynn RW, Mann LS, Bunney WE, Sokoloff L. Cerebral glucography with positron tomography. Arch Gen Psychiatry. 1982;39: 251–259.
114. Robinson RG, Kubos KL, Starr LB, Rao K, Price TR. Mood disorders in stroke patients: importance of location of lesion. Brain. 1984;107: 81–93.
115. Robinson RG, Starkstein SE. Current research in affective disorders following stroke. J Neuropsychiatry Clin Neurosci. 1990;2: 1–4.
116. Walker EF, Harvey PD, Perlman D. The positive/negative symptom distinction in psychoses: a replication and extension of previous findings. J Nerv Ment Dis. 1988;176: 359–363.
117. Klimidis S, Stuart GW, Minas IH, Copolov DL, Singh BS. Positive and negative symptoms in the psychoses: re-analysis of published SAPS and SANS global ratings. Schizophr Res. 1993;9: 11–18.